United States Prostate Cancer Drugs Market Report & Forecast 2021-2027

United States Prostate Cancer Drugs Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Prostate Cancer Drugs Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Prostate Cancer Drugs Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Prostate Cancer Drugs Overall Market Size
2.1 United States Prostate Cancer Drugs Market Size: 2021 VS 2027
2.2 United States Prostate Cancer Drugs Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Prostate Cancer Drugs Sales: 2016-2027
3 Company Landscape
3.1 Top Prostate Cancer Drugs Players in United States Market
3.2 Top United States Prostate Cancer Drugs Companies Ranked by Revenue
3.3 United States Prostate Cancer Drugs Revenue by Companies
3.4 United States Prostate Cancer Drugs Sales by Companies
3.5 United States Prostate Cancer Drugs Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Prostate Cancer Drugs Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Prostate Cancer Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Prostate Cancer Drugs Players in United States Market
3.8.1 List of Tier 1 Prostate Cancer Drugs Companies in United States
3.8.2 List of Tier 2 and Tier 3 Prostate Cancer Drugs Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Prostate Cancer Drugs Market Size Markets, 2021 & 2027
4.1.2 Hormonal Therapy
4.1.3 Chemotherapy
4.1.4 Immunotherapy
4.1.5 Targeted Therapy
4.2 By Type - United States Prostate Cancer Drugs Revenue & Forecasts
4.2.1 By Type - United States Prostate Cancer Drugs Revenue, 2016-2021
4.2.2 By Type - United States Prostate Cancer Drugs Revenue, 2022-2027
4.2.3 By Type - United States Prostate Cancer Drugs Revenue Market Share, 2016-2027
4.3 By Type - United States Prostate Cancer Drugs Sales & Forecasts
4.3.1 By Type - United States Prostate Cancer Drugs Sales, 2016-2021
4.3.2 By Type - United States Prostate Cancer Drugs Sales, 2022-2027
4.3.3 By Type - United States Prostate Cancer Drugs Sales Market Share, 2016-2027
4.4 By Type - United States Prostate Cancer Drugs Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Prostate Cancer Drugs Market Size, 2021 & 2027
5.1.2 Clinics
5.1.3 Hospitals
5.1.4 Others
5.2 By Application - United States Prostate Cancer Drugs Revenue & Forecasts
5.2.1 By Application - United States Prostate Cancer Drugs Revenue, 2016-2021
5.2.2 By Application - United States Prostate Cancer Drugs Revenue, 2022-2027
5.2.3 By Application - United States Prostate Cancer Drugs Revenue Market Share, 2016-2027
5.3 By Application - United States Prostate Cancer Drugs Sales & Forecasts
5.3.1 By Application - United States Prostate Cancer Drugs Sales, 2016-2021
5.3.2 By Application - United States Prostate Cancer Drugs Sales, 2022-2027
5.3.3 By Application - United States Prostate Cancer Drugs Sales Market Share, 2016-2027
5.4 By Application - United States Prostate Cancer Drugs Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 AbbVie
6.1.1 AbbVie Corporation Information
6.1.2 AbbVie Overview
6.1.3 AbbVie Prostate Cancer Drugs Sales and Revenue in United States Market (2016-2021)
6.1.4 AbbVie Prostate Cancer Drugs Product Description
6.1.5 AbbVie Recent Developments
6.2 Astellas Pharma
6.2.1 Astellas Pharma Corporation Information
6.2.2 Astellas Pharma Overview
6.2.3 Astellas Pharma Prostate Cancer Drugs Sales and Revenue in United States Market (2016-2021)
6.2.4 Astellas Pharma Prostate Cancer Drugs Product Description
6.2.5 Astellas Pharma Recent Developments
6.3 Astra Zeneca
6.3.1 Astra Zeneca Corporation Information
6.3.2 Astra Zeneca Overview
6.3.3 Astra Zeneca Prostate Cancer Drugs Sales and Revenue in United States Market (2016-2021)
6.3.4 Astra Zeneca Prostate Cancer Drugs Product Description
6.3.5 Astra Zeneca Recent Developments
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Corporation Information
6.4.2 Johnson & Johnson Overview
6.4.3 Johnson & Johnson Prostate Cancer Drugs Sales and Revenue in United States Market (2016-2021)
6.4.4 Johnson & Johnson Prostate Cancer Drugs Product Description
6.4.5 Johnson & Johnson Recent Developments
6.5 Sanofi
6.5.1 Sanofi Corporation Information
6.5.2 Sanofi Overview
6.5.3 Sanofi Prostate Cancer Drugs Sales and Revenue in United States Market (2016-2021)
6.5.4 Sanofi Prostate Cancer Drugs Product Description
6.5.5 Sanofi Recent Developments
6.6 GlaxoSmithKline
6.6.1 GlaxoSmithKline Corporation Information
6.6.2 GlaxoSmithKline Overview
6.6.3 GlaxoSmithKline Prostate Cancer Drugs Sales and Revenue in United States Market (2016-2021)
6.6.4 GlaxoSmithKline Prostate Cancer Drugs Product Description
6.6.5 GlaxoSmithKline Recent Developments
6.7 Merck Group
6.7.1 Merck Group Corporation Information
6.7.2 Merck Group Overview
6.7.3 Merck Group Prostate Cancer Drugs Sales and Revenue in United States Market (2016-2021)
6.7.4 Merck Group Prostate Cancer Drugs Product Description
6.7.5 Merck Group Recent Developments
6.8 Novartis
6.8.1 Novartis Corporation Information
6.8.2 Novartis Overview
6.8.3 Novartis Prostate Cancer Drugs Sales and Revenue in United States Market (2016-2021)
6.8.4 Novartis Prostate Cancer Drugs Product Description
6.8.5 Novartis Recent Developments
6.9 Amgen
6.9.1 Amgen Corporation Information
6.9.2 Amgen Overview
6.9.3 Amgen Prostate Cancer Drugs Sales and Revenue in United States Market (2016-2021)
6.9.4 Amgen Prostate Cancer Drugs Product Description
6.9.5 Amgen Recent Developments
6.10 Bayer HealthCare
6.10.1 Bayer HealthCare Corporation Information
6.10.2 Bayer HealthCare Overview
6.10.3 Bayer HealthCare Prostate Cancer Drugs Sales and Revenue in United States Market (2016-2021)
6.10.4 Bayer HealthCare Prostate Cancer Drugs Product Description
6.10.5 Bayer HealthCare Recent Developments
6.11 Ferring Pharmaceutical
6.11.1 Ferring Pharmaceutical Corporation Information
6.11.2 Ferring Pharmaceutical Overview
6.11.3 Ferring Pharmaceutical Prostate Cancer Drugs Sales and Revenue in United States Market (2016-2021)
6.11.4 Ferring Pharmaceutical Prostate Cancer Drugs Product Description
6.11.5 Ferring Pharmaceutical Recent Developments
6.12 Janssen Pharmaceuticals
6.12.1 Janssen Pharmaceuticals Corporation Information
6.12.2 Janssen Pharmaceuticals Overview
6.12.3 Janssen Pharmaceuticals Prostate Cancer Drugs Sales and Revenue in United States Market (2016-2021)
6.12.4 Janssen Pharmaceuticals Prostate Cancer Drugs Product Description
6.12.5 Janssen Pharmaceuticals Recent Developments
6.13 Endo Pharmaceuticals
6.13.1 Endo Pharmaceuticals Corporation Information
6.13.2 Endo Pharmaceuticals Overview
6.13.3 Endo Pharmaceuticals Prostate Cancer Drugs Sales and Revenue in United States Market (2016-2021)
6.13.4 Endo Pharmaceuticals Prostate Cancer Drugs Product Description
6.13.5 Endo Pharmaceuticals Recent Developments
6.14 BMS
6.14.1 BMS Corporation Information
6.14.2 BMS Overview
6.14.3 BMS Prostate Cancer Drugs Sales and Revenue in United States Market (2016-2021)
6.14.4 BMS Prostate Cancer Drugs Product Description
6.14.5 BMS Recent Developments
6.15 Takeda Pharmaceuticals
6.15.1 Takeda Pharmaceuticals Corporation Information
6.15.2 Takeda Pharmaceuticals Overview
6.15.3 Takeda Pharmaceuticals Prostate Cancer Drugs Sales and Revenue in United States Market (2016-2021)
6.15.4 Takeda Pharmaceuticals Prostate Cancer Drugs Product Description
6.15.5 Takeda Pharmaceuticals Recent Developments
6.16 Northwest Biotherapeutics
6.16.1 Northwest Biotherapeutics Corporation Information
6.16.2 Northwest Biotherapeutics Overview
6.16.3 Northwest Biotherapeutics Prostate Cancer Drugs Sales and Revenue in United States Market (2016-2021)
6.16.4 Northwest Biotherapeutics Prostate Cancer Drugs Product Description
6.16.5 Northwest Biotherapeutics Recent Developments
6.17 Teva Pharmaceutical
6.17.1 Teva Pharmaceutical Corporation Information
6.17.2 Teva Pharmaceutical Overview
6.17.3 Teva Pharmaceutical Prostate Cancer Drugs Sales and Revenue in United States Market (2016-2021)
6.17.4 Teva Pharmaceutical Prostate Cancer Drugs Product Description
6.17.5 Teva Pharmaceutical Recent Developments
6.18 Boehringer Ingelheim
6.18.1 Boehringer Ingelheim Corporation Information
6.18.2 Boehringer Ingelheim Overview
6.18.3 Boehringer Ingelheim Prostate Cancer Drugs Sales and Revenue in United States Market (2016-2021)
6.18.4 Boehringer Ingelheim Prostate Cancer Drugs Product Description
6.18.5 Boehringer Ingelheim Recent Developments
6.19 Foresee Pharmaceuticals
6.19.1 Foresee Pharmaceuticals Corporation Information
6.19.2 Foresee Pharmaceuticals Overview
6.19.3 Foresee Pharmaceuticals Prostate Cancer Drugs Sales and Revenue in United States Market (2016-2021)
6.19.4 Foresee Pharmaceuticals Prostate Cancer Drugs Product Description
6.19.5 Foresee Pharmaceuticals Recent Developments
6.20 Tokai Pharmaceuticals
6.20.1 Tokai Pharmaceuticals Corporation Information
6.20.2 Tokai Pharmaceuticals Overview
6.20.3 Tokai Pharmaceuticals Prostate Cancer Drugs Sales and Revenue in United States Market (2016-2021)
6.20.4 Tokai Pharmaceuticals Prostate Cancer Drugs Product Description
6.20.5 Tokai Pharmaceuticals Recent Developments
6.21 Spectrum Pharmaceuticals
6.21.1 Spectrum Pharmaceuticals Corporation Information
6.21.2 Spectrum Pharmaceuticals Overview
6.21.3 Spectrum Pharmaceuticals Prostate Cancer Drugs Sales and Revenue in United States Market (2016-2021)
6.21.4 Spectrum Pharmaceuticals Prostate Cancer Drugs Product Description
6.21.5 Spectrum Pharmaceuticals Recent Developments
7 United States Prostate Cancer Drugs Production Capacity, Analysis
7.1 United States Prostate Cancer Drugs Production Capacity, 2016-2027
7.2 Prostate Cancer Drugs Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Prostate Cancer Drugs Supply Chain Analysis
9.1 Prostate Cancer Drugs Industry Value Chain
9.2 Prostate Cancer Drugs Upstream Market
9.3 Prostate Cancer Drugs Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Prostate Cancer Drugs Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of Prostate Cancer Drugs in United States Market
Table 2. Top Prostate Cancer Drugs Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Prostate Cancer Drugs Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Prostate Cancer Drugs Revenue Share by Companies, 2016-2021
Table 5. United States Prostate Cancer Drugs Sales by Companies, (K MT), 2016-2021
Table 6. United States Prostate Cancer Drugs Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Prostate Cancer Drugs Price (2016-2021) & (USD/MT)
Table 8. Manufacturers Prostate Cancer Drugs Product Type
Table 9. List of Tier 1 Prostate Cancer Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Prostate Cancer Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Hormonal Therapy
Table 12. Major Manufacturers of Chemotherapy
Table 13. By Type - United States Prostate Cancer Drugs Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Prostate Cancer Drugs Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Prostate Cancer Drugs Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Prostate Cancer Drugs Sales (K MT), 2016-2021
Table 17. By Type - United States Prostate Cancer Drugs Sales (K MT), 2022-2027
Table 18. By Application - United States Prostate Cancer Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Prostate Cancer Drugs Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Prostate Cancer Drugs Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Prostate Cancer Drugs Sales (K MT), 2016-2021
Table 22. By Application - United States Prostate Cancer Drugs Sales (K MT), 2022-2027
Table 23. AbbVie Corporation Information
Table 24. AbbVie Description and Major Businesses
Table 25. AbbVie Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 26. AbbVie Prostate Cancer Drugs Product
Table 27. AbbVie Recent Developments
Table 28. Astellas Pharma Corporation Information
Table 29. Astellas Pharma Description and Major Businesses
Table 30. Astellas Pharma Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 31. Astellas Pharma Prostate Cancer Drugs Product
Table 32. Astellas Pharma Recent Developments
Table 33. Astra Zeneca Corporation Information
Table 34. Astra Zeneca Description and Major Businesses
Table 35. Astra Zeneca Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 36. Astra Zeneca Prostate Cancer Drugs Product
Table 37. Astra Zeneca Recent Developments
Table 38. Johnson & Johnson Corporation Information
Table 39. Johnson & Johnson Description and Major Businesses
Table 40. Johnson & Johnson Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 41. Johnson & Johnson Prostate Cancer Drugs Product
Table 42. Johnson & Johnson Recent Developments
Table 43. Sanofi Corporation Information
Table 44. Sanofi Description and Major Businesses
Table 45. Sanofi Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 46. Sanofi Prostate Cancer Drugs Product
Table 47. Sanofi Recent Developments
Table 48. GlaxoSmithKline Corporation Information
Table 49. GlaxoSmithKline Description and Major Businesses
Table 50. GlaxoSmithKline Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 51. GlaxoSmithKline Prostate Cancer Drugs Product
Table 52. GlaxoSmithKline Recent Developments
Table 53. Merck Group Corporation Information
Table 54. Merck Group Description and Major Businesses
Table 55. Merck Group Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 56. Merck Group Prostate Cancer Drugs Product
Table 57. Merck Group Recent Developments
Table 58. Novartis Corporation Information
Table 59. Novartis Description and Major Businesses
Table 60. Novartis Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 61. Novartis Prostate Cancer Drugs Product
Table 62. Novartis Recent Developments
Table 63. Amgen Corporation Information
Table 64. Amgen Description and Major Businesses
Table 65. Amgen Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 66. Amgen Prostate Cancer Drugs Product
Table 67. Amgen Recent Developments
Table 68. Bayer HealthCare Corporation Information
Table 69. Bayer HealthCare Description and Major Businesses
Table 70. Bayer HealthCare Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 71. Bayer HealthCare Prostate Cancer Drugs Product
Table 72. Bayer HealthCare Recent Developments
Table 73. Ferring Pharmaceutical Corporation Information
Table 74. Ferring Pharmaceutical Description and Major Businesses
Table 75. Ferring Pharmaceutical Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 76. Ferring Pharmaceutical Prostate Cancer Drugs Product
Table 77. Ferring Pharmaceutical Recent Developments
Table 78. Janssen Pharmaceuticals Corporation Information
Table 79. Janssen Pharmaceuticals Description and Major Businesses
Table 80. Janssen Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 81. Janssen Pharmaceuticals Prostate Cancer Drugs Product
Table 82. Janssen Pharmaceuticals Recent Developments
Table 83. Endo Pharmaceuticals Corporation Information
Table 84. Endo Pharmaceuticals Description and Major Businesses
Table 85. Endo Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 86. Endo Pharmaceuticals Prostate Cancer Drugs Product
Table 87. Endo Pharmaceuticals Recent Developments
Table 88. BMS Corporation Information
Table 89. BMS Description and Major Businesses
Table 90. BMS Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 91. BMS Prostate Cancer Drugs Product
Table 92. BMS Recent Developments
Table 93. Takeda Pharmaceuticals Corporation Information
Table 94. Takeda Pharmaceuticals Description and Major Businesses
Table 95. Takeda Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 96. Takeda Pharmaceuticals Prostate Cancer Drugs Product
Table 97. Takeda Pharmaceuticals Recent Developments
Table 98. Northwest Biotherapeutics Corporation Information
Table 99. Northwest Biotherapeutics Description and Major Businesses
Table 100. Northwest Biotherapeutics Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 101. Northwest Biotherapeutics Prostate Cancer Drugs Product
Table 102. Northwest Biotherapeutics Recent Developments
Table 103. Teva Pharmaceutical Corporation Information
Table 104. Teva Pharmaceutical Description and Major Businesses
Table 105. Teva Pharmaceutical Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 106. Teva Pharmaceutical Prostate Cancer Drugs Product
Table 107. Teva Pharmaceutical Recent Developments
Table 108. Boehringer Ingelheim Corporation Information
Table 109. Boehringer Ingelheim Description and Major Businesses
Table 110. Boehringer Ingelheim Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 111. Boehringer Ingelheim Prostate Cancer Drugs Product
Table 112. Boehringer Ingelheim Recent Developments
Table 113. Foresee Pharmaceuticals Corporation Information
Table 114. Foresee Pharmaceuticals Description and Major Businesses
Table 115. Foresee Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 116. Foresee Pharmaceuticals Prostate Cancer Drugs Product
Table 117. Foresee Pharmaceuticals Recent Developments
Table 118. Tokai Pharmaceuticals Corporation Information
Table 119. Tokai Pharmaceuticals Description and Major Businesses
Table 120. Tokai Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 121. Tokai Pharmaceuticals Prostate Cancer Drugs Product
Table 122. Tokai Pharmaceuticals Recent Developments
Table 123. Spectrum Pharmaceuticals Corporation Information
Table 124. Spectrum Pharmaceuticals Description and Major Businesses
Table 125. Spectrum Pharmaceuticals Prostate Cancer Drugs Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 126. Spectrum Pharmaceuticals Prostate Cancer Drugs Product
Table 127. Spectrum Pharmaceuticals Recent Developments
Table 128. Prostate Cancer Drugs Production Capacity (K MT) of Key Manufacturers in United States Market, 2019-2021 (K MT)
Table 129. United States Prostate Cancer Drugs Capacity Market Share of Key Manufacturers, 2019-2021
Table 130. Prostate Cancer Drugs Market Opportunities & Trends in United States Market
Table 131. Prostate Cancer Drugs Market Drivers in United States Market
Table 132. Prostate Cancer Drugs Market Restraints in United States Market
Table 133. Prostate Cancer Drugs Raw Materials
Table 134. Prostate Cancer Drugs Raw Materials Suppliers in United States Market
Table 135. Typical Prostate Cancer Drugs Downstream
Table 136. Prostate Cancer Drugs Downstream Clients in United States Market
Table 137. Prostate Cancer Drugs Distributors and Sales Agents in United States Market
List of Figures
Figure 1. Prostate Cancer Drugs Product Picture
Figure 2. Prostate Cancer Drugs Segment by Type
Figure 3. Prostate Cancer Drugs Segment by Application
Figure 4. United States Prostate Cancer Drugs Market Overview: 2020
Figure 5. United States Prostate Cancer Drugs Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Prostate Cancer Drugs Revenue, 2016-2027 (US$, Mn)
Figure 7. Prostate Cancer Drugs Sales in United States Market: 2016-2027 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Prostate Cancer Drugs Revenue in 2020
Figure 9. Hormonal Therapy Product Picture
Figure 10. Chemotherapy Product Picture
Figure 11. Immunotherapy Product Picture
Figure 12. Targeted Therapy Product Picture
Figure 13. By Type - United States Prostate Cancer Drugs Sales Market Share, 2016-2027
Figure 14. By Type - United States Prostate Cancer Drugs Revenue Market Share, 2016-2027
Figure 15. By Type - United States Prostate Cancer Drugs Price (USD/MT), 2016-2027
Figure 16. Clinics
Figure 17. Hospitals
Figure 18. Others
Figure 19. By Application - United States Prostate Cancer Drugs Sales Market Share, 2016-2027
Figure 20. By Application - United States Prostate Cancer Drugs Revenue Market Share, 2016-2027
Figure 21. By Application - United States Prostate Cancer Drugs Price (USD/MT), 2016-2027
Figure 22. AbbVie Prostate Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Astellas Pharma Prostate Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Astra Zeneca Prostate Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Johnson & Johnson Prostate Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Sanofi Prostate Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. GlaxoSmithKline Prostate Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Merck Group Prostate Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. Novartis Prostate Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. Amgen Prostate Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. Bayer HealthCare Prostate Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 32. Ferring Pharmaceutical Prostate Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 33. Janssen Pharmaceuticals Prostate Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 34. Endo Pharmaceuticals Prostate Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 35. BMS Prostate Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 36. Takeda Pharmaceuticals Prostate Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 37. Northwest Biotherapeutics Prostate Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Teva Pharmaceutical Prostate Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Boehringer Ingelheim Prostate Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Foresee Pharmaceuticals Prostate Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Tokai Pharmaceuticals Prostate Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Spectrum Pharmaceuticals Prostate Cancer Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. United States Prostate Cancer Drugs Production Capacity (K MT), 2016-2027
Figure 44. Prostate Cancer Drugs Industry Value Chain
Figure 45. Marketing Channels

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global 5-Fluorouracil Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76

The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......

Global Carboplatin Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......

Global Neutropenia Drugs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96

The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......

Global Small Molecule Cancer Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......

Global Capecitabine Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80

Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......

Global Oxaliplatin Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104

Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......

Global Cancer Treatment Drugs Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158

According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......

Global Capecitabine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93

According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......

Global Methotrexate Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs